2016 Agenda - Under Development
Emilie Becker, M.D.
|Collin Hovinga, Pharm.D., M.S., FCCP
Director of Research
Clinical Associate Professor
The University of Texas at Austin College of Pharmacy
|Steven R. Pliszka, M.D.
Dielmann Distinguished Professor and Chair
Department of Psychiatry
The University of Texas Health and Science Center San Antonio
|Vicki Ellingrod, Pharm.D.
Professor and Associate Chair for Research and Mentorship
University of Michigan College of Pharmacy
|Alicia Kowalchuk, D.O.
Assistant Professor, Department of Family and Community Medicine
Baylor College of Medicine
|Stephen R. Saklad, Pharm.D., BCPP
Clinical Associate Professor,
The University of Texas at Austin College of Pharmacy
|Graham Emslie, M.D.
Professor of Psychiatry
Director, Division of Child and Adolescent Psychiatry
The University of Texas Southwestern Medical Center at Dallas
|Sanjay Mathew, M.D.
Michael E. DeBakey VA Medical Ctr Houston
|Ashley Smith, Pharm.D., BCPP
Clinical Pharmacy Specialist, Psychiatry
Mental Health Outpatient Services
South Texas Veterans Health Care System
|Martha Fankhauser, MS Pharm, BCPP, FASHP
University of Arizona College of Pharmacy
|David Morôn, M.D.
Clinical Director, Psychiatrist
Rio Grande State Center
|Rajesh Tampi, M.D., DFAPA
Vice Chairman for Education Adult Psychiatry Residency Program Director
Professor of Psychiatry, Case Western Reserve University School of Medicine Chief of Geriatric Psychiatry, MetroHealth
|Issac Pan, Pharm.D.
Psychiatric Pharmacy Resident
The University of Texas at Austin College of Pharmacy
Emilie Becker, M.D.
Dr. Becker has worked for the last 25 years in the area of psychiatric mental health in the state of Texas. She began as a child psychiatrist at a local community mental health clinic seeing abused patients admitted to Child Protective Services. She then migrated to a private practice where she acquired her forensic psychiatry boards and testified at numerous hearings. Later she worked at several rural state run juvenile prisons, one for sexual offenders. Dr. Becker then returned to Austin to work at Austin State Hospital, where she ran the female teen unit and afterwards, an adult inpatient unit. She left to work for the Texas Department of State Health Services where she became the Behavioral Health Medical Director. She then transferred to Texas Medicaid, and is the Mental Health Medical Director there. Dr. Becker has published numerous articles in the arena of public mental health.
Vicki Ellingrod, Pharm.D.
Vicki L Ellingrod, PharmD, BCPP, FCCP, is Head of the Clinical Pharmacogenomics Laboratory and Associate Professor in the Department of Psychiatry at the University of Michigan in Ann Arbor, MI. She received her Doctorate in Pharmacy at the University of Minnesota in Minneapolis, MN before completing clinical fellowships in psychopharmacology at the University of Iowa College of Pharmacy in Iowa City, IA. She is a member of numerous professional societies including the University of Michigan Comprehensive Depression Center Steering Committee, the Michigan Metabolomics and Obesity Center (MMOC), and Scientific Review/Research Committee at the Michigan Institute for Clinical Research (MICHR). She is the Psychopharmacology Department Editor for Current Psychiatry and Director of the Pharmacogenomics Laboratory at the University of Michigan College of Pharmacy. Her current research projects focus on investigating the metabolic side effects of atypical antipsychotics. As a member of the Scientific Review Committee, she was the recipient of the Clinical and Translational Science Award by the National Institutes of Health. Her work has been published in several book chapters and peer-reviewed journals including Pharmacogenomics, Current Psychiatry Reports, and Epigenomics. She has also been invited to present her work at conferences across the nation.
Graham Emslie, MD
Dr. Emslie obtained his undergraduate degree and M.D. at Aberdeen University in Aberdeen, Scotland in 1974. Dr. Emslie did his internship at Aberdeen Hospitals, Scotland in general medicine and neurosurgery. He did his residency training in general psychiatry at the University of Rochester, NY and child psychiatry at Stanford University, where he also completed a research fellowship.
Dr. Emslie joined the U.T. Southwestern Faculty in 1981. He has served as Director for both the inpatient and outpatient units of Children’s Medical Center’s Psychiatry Division. Currently, Dr. Emslie is the Chief of Adolescent Psychiatry program at UT Southwestern and Children’s Medical Center of Dallas. Dr. Emslie’s clinical expertise is in the area of child and adolescent depression.
Dr. Emslie’s research foci are in the areas of conducting efficacy and effectiveness trials with medications and psychotherapy for children and adolescents with depression, anxiety disorders, and attention-deficit disorder. He is also involved with developing and evaluating medication algorithm protocols for children and adolescents with depression. Dr. Emslie has authored or co-authored over 180 papers and 27 chapters. He is known internationally for his work in the treatment of pediatric depression. In 2003, he was awarded the Klingenstein Third generation Foundation Award for his work in this field.
Martha Fankhauser, MS Pharm., BCPP, FASHP
Martha (Martie) Fankhauser, MS Pharm, FASHP, BCPP, received a B.A. in Biology in 1972 and B.S. in Pharmacy in 1974 from the University of Kansas. In 1982, she received a M.S. in Pharmacy and a post-graduate psychiatry residency from the University of Arizona. She was a Clinical Professor in the Department of Pharmacy Practice, College of Pharmacy at the University of Arizona College of Pharmacy from 1982 to 2010 and was the director for a Neuropsychiatric Pharmacy Practice Residency Program. After retirement, she worked as a Pharmacotherapy Specialist for Arizona Smokers' Helpline at the Mel and Enid Zuckerman College of Public Health and helped psychiatric patients quit smoking. Ms. Fankhauser was involved with the development of Board Certification of Psychiatric Pharmacy (BCPP) and participates in a Psychiatry Certificate Program through the Arizona Pharmacy Association. She has a private neuropsychiatric consulting practice and provides guidance and recommendations for individuals who want an assessment of their medications, over-the-counter products, and complementary medicine treatments.
Ms. Fankhauser works part-time as a Medication Management Specialist at SinfoníaRx for the Assurance Health and Wellness Center, an integrated medical-psychiatry clinic. She has served as a board member for the Tourette Syndrome Association of Arizona and the CPNP Foundation. She is a board member of the Autism Society of Southern Arizona and serves on the Education Committee and Professional Advisory Council. Her interests are in preventative health/wellness interventions and include the relationship of nutrition, exercise, sleep, hormonal changes, and vitamin D deficiency on neuropsychiatric disorders; polypharmacy of psychotropic agents; pharmacokinetic/ pharmacodynamic drug interactions; substance use disorders; tobacco cessation; women's health issues; and pain management. Her family now has 3 generations of pharmacists, including her father and son.
Collin Hovinga, Pharm.D., M.S., FCCP
Doctor Hovinga completed his Bachelor of Science Degree in Biology and Doctor of Pharmacy (1997) degrees from Creighton University in Omaha, Nebraska. After which he pursued a Residency and Fellowship in Pediatric Pharmacotherapy with emphasis in Pediatric Neuroscience at the University of Tennessee, Memphis, LeBonheur Children’s Medical Center. He completed a second a Fellowship at the Food and Drug Administration Office of Clinical Pharmacology and a Masters of Epidemiology from the University of Tennessee Health Science Center Doctor Hovinga has been active in studying the genetic effects on the susceptibility of neonates to hypoxia-induced seizures and in studying the pharmacogenetics of medications in the treatment of epilepsy and autism. Dr. Hovinga is recognized as an expert in neuropharmacology and holds an appointment to the FDA’s PNS and CNS Advisory Committee and Editorial Board for Lexicomp and other Pharmacology journals. Dr. Hovinga has had leadership roles in neuroprotective drug pharmacology NIH projects (Clinical Investigations for Neuroprotective Agents in Parkinson’s Syndrome (CINAPS)) and for Huntington’s Disease (SET-HD) and in pediatric stroke (IPSS, TIPS). Dr. Hovinga’s understanding of developmental pharmacology and pediatric brain injury has made him unique in the pharmacology arena and has led to him being a journal reviewer and an invited speaker at many national organizational meetings. He currently serves as Director of Research at PSS/Dell Children’s Medical Center and is Faculty at UT Austin.
Research Interests: Epilepsy, Autism, Stroke, Pediatric Pharmacogenomics, and Epidemiology of Healthcare in Children
Alicia Kowalchuk, D.O.
Dr. Alicia Kowalchuk is an associate professor with Baylor College of Medicine’s (BCM) Department of Family and Community Medicine and board certified in both family medicine and addiction medicine. She is medical director of InSight, the screening, brief intervention and referral to treatment (SBIRT) program for the Harris Health System, which is the county-funded health care system for the greater Houston area’s over one million uninsured residents. She served as core faculty for the Substance Abuse and Mental Health Services Association (SAMHSA) funded BCM SBIRT residency training program and is course director for the BCM first year medical student course “Patient, Physician and Society I and II” which teaches basic physical examination and patient interviewing skills. In her SBIRT roles, she has developed and implemented in person, online and mobile application curricula on SBIRT as well as addiction medicine topics including pain and addiction. She also serves as medical director at Santa Maria Hostel (SMH) which provides state-funded residential drug treatment to women and their children in the greater Houston community, and the Houston Recovery Center which operates a Sobering Center in partnership with the City of Houston and the Houston Police Department. She is part of a new SAMHSA funded initiative, the MIRRORS project, which will expand and integrate on site primary care and behavioral health services for women clients and their extended families at SMH.
In her previous work on the Center for Disease Control (CDC) funded randomized controlled trial of the CHOICES Plus counseling intervention, which focused on reducing alcohol and tobacco exposed pregnancy (AEP/TEP) risk in preconceptive women presenting for primary care services at Harris Health, she developed a curriculum to inform primary care providers about AEP and TEP consequences and prevention and facilitated the intervention’s integration into clinic work flows. As core faculty of the recently CDC funded Southern States Fetal Alcohol Spectrum Disorder Practice and Implementation Center (FASD PIC), she will focus on SBI curricular development. Dr. Kowalchuk graduated from New York College of Osteopathic Medicine and performed her internship at St. Clare’s Hospital in Manhattan. She completed her family medicine residency at Montefiore Medical Center in the Bronx and then served three years with the National Health Corps providing on site prenatal, HIV, primary care and addiction medicine services at a methadone clinic in the South Bronx. She relocated to Houston in 2004 and joined the BCM faculty, working as a family physician in a community health center before joining the InSight program. Her passion is caring for families affected by addiction and educating other healthcare professionals and students about effectively
Sanjay Mathew, M.D.
Sanjay J. Mathew, M.D. is a Staff Physician and Director of the Mood and Anxiety Disorders Research Program in the Mental Health Care Line at the Michael E. Debakey VA Medical Center. At Baylor College of Medicine (BCM), he holds the Johnson Family Chair for Research in Psychiatry and is an Associate Professor with Tenure in the Menninger Department of Psychiatry and Behavioral Sciences. Dr. Mathew’s research program is the recipient of federal NIH grants and contracts to develop novel therapies for patients with serious, treatment-resistant mood disorders and PTSD. His program has special interest in novel pharmacotherapies which impact the stress response and enhance neuroplasticity, which include agents which modulate the glutamatergic, HPA axis, and opiate systems. His team is at the forefront of research on the application of low-dose ketamine, an anesthetic agent, for the rapid relief of severe depression and suicidality.
David Morôn, M.D.
Clinical Director at Rio Grande State Center
Issac Pan, Pharm.D.
Dr. Pan obtained his BS in biology and from University of Texas at Austin (UT Austin, and subsequently finished his Pharm.D. degree in UT Austin and University of Texas Health Science Center San Antonio (UTHSCSA). Before coming back to the MS/residency program, he worked at the San Angelo State Supported Living Center. Dr. Pan is currently a pharmaceutical science graduate student and psychiatric pharmacy resident at the Pharmacotherapy Division of UT Austin and the Pharmacotherapy Education & Research Center at UTHSCSA. His research focus is on disparity in clozapine use due to benign ethnic neutropenia.
Steven R. Pliszka, M.D.
Steven R. Pliszka, M.D. is Chair of the Department of Psychiatry of the University of Texas Health Science Center at San Antonio. He has been a faculty member at UTHSCSA since 1986, joining the Department of Psychiatry after completing his general and child adolescent psychiatry residencies at UTHSCSA. Throughout his career he has been involved in a wide range of administrative, research, clinical and educational activities. Prior to being Chair he served as Chief of the Division of Child and Adolescent Psychiatry from 1995-2015.
His research has focused on Attention Deficit Hyperactivity Disorder (ADHD) and related disorders. He has been involved with clinical trials of the most medications used for ADHD. He currently uses functional magnetic imaging to try to understand the mechanisms of action of treatments for ADHD. He has been involved in several projects to integrate mental health services into pediatric primary care.
Dr. Pliszka is the author of Neuroscience for the Mental Health Clinician and Treating ADHD and Comorbid Disorders (Guilford Press). He has been very active in the American Academy of Child and Adolescent Psychiatry, authoring the academys practice parameters for the diagnosis and treatment of ADHD in 2007.
Dr. Pliszka has an active clinical practice, caring for many children and adolescents with ADHD and other psychiatric disorders; he also serves as the attending psychiatrist for two residential facilities for children with severe behavioral and emotional disorders.
Stephen R. Saklad, Pharm.D., BCPP
Dr Saklad joined the faculty of The University of Texas College of Pharmacy and the staff of San Antonio State Hospital in 1979. He has focused on providing the excellent teaching and pharmaceutical care to improve the quality of life and function in the serious and persistently mentally ill. He wrote and successfully lobbied for the creation of a clinical research unit at San Antonio State Hospital funded by the Texas Legislature and governed by the College of Pharmacy, Department of Psychiatry and San Antonio State Hospital. He developed the first websites for The University of Texas College of Pharmacy in 1994 and the College of Psychiatric and Neurologic Pharmacists (CPNP) in 1997. He is Director of the University of Texas Psychiatric Pharmacy Program in San Antonio, Founding Member of CPNP, served on the CPNP Board of Directors, and was the founding senior editor of their journal, the Mental Health Clinician. He has served as the clinical chair of The University of Texas Psychiatric Pharmacotherapy Update since 2005. He has published articles and presented to many groups around the country on a variety of pharmacy and mental health related topics. He is a principal or co-investigator for several studies of the efficacy and adverse effects of Phase II, III, and IV psychotropic agents in schizophrenia, mood disorders, and other serious mental illnesses, as well as their pharmacokinetics and interactions. He has received several honors, most recently the Judith J. Saklad Memorial Award from CPNP in 2012 and Teaching Excellence Award from the UT College of Pharmacy in 2013.
Ashley Smith, Pharm.D., BCPP
Ashley G. Smith, PharmD, BCPP, is a clinical pharmacy specialist for the South Texas Veterans Healthcare System at Frank Tejeda – Mental Health Outpatient Services. Dr. Smith received her Doctorate in Pharmacy at the University of Louisiana – Monroe and completed residencies at the VA Medical Center in Salem, Virginia and at the South Texas VA. Prior to returning to the VA for her current position, she worked at the San Antonio State Supported Living Center. Due to her interest and the growing need at VA for care of this population, Dr. Smith serves as a resource for treatment of pregnant women with psychiatric symptoms.
Rajesh Tampi, M.D., MS, FAPA
Dr. Tampi is the Vice Chairman for Education, Residency Program Director and the Chief of Geriatric Psychiatry at MetroHealth, Cleveland, Ohio. His application is being reviewed by the Dean for appointment as Professor of Psychiatry at Case Western Reserve University School of Medicine. Dr. Tampi maintains his appointment as an Associate Clinical Professor of Psychiatry at Yale University School of Medicine. He trained in Psychiatry at the University of Leeds in England and the University of Vermont in Burlington, Vermont. During his residency training in England, Dr. Tampi also attained a Post Graduate Diploma in Clinical Psychiatry from the University in Leeds. He completed his Geriatric Psychiatry Fellowship at Yale University School of Medicine, New Haven, CT. He is the President Elect of the International Medical Graduates (IMG) Caucus of the American Psychiatric Association. Dr. Tampi has received three ‘Outstanding Teaching Attending Awards’ and the ‘Chairman’s Award’ for outstanding teaching, research, and clinical work from the Department of Psychiatry at Yale University School of Medicine. He is a recipient of the Geriatric Academic Career Award (GACA) instituted by the Department of Health and Human Services (DHHS). Dr. Tampi was a recipient of the American Association for Geriatric Psychiatry, 2013-Clinician of the Year Award. He is a Distinguished Fellow at the American Psychiatric Association. He has published over 60 articles in peer reviewed national and international journals on various topics in geriatric psychiatry. In addition, Dr. Tampi is a chief editor for three books in psychiatry. He serves on the editorial board of various peer reviewed national and international journals in psychiatry and is a reviewer for over 20 journals including the American Journal of Geriatric Psychiatry, American Journal of Psychiatry, and the American Journal of Alzheimer’s Disease and other Dementias. Dr. Tampi’s clinical and research interests are psychiatric disorders in late life, neurodegenerative disorders, ethical & legal issues in geriatric psychiatry and integrated geriatric psychiatric care.
|The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.|
|Comments to: UTPharmacyCE@austin.utexas.edu
Download free PDF Reader | Download free MS Reader
©2012 College of Pharmacy, The University of Texas at Austin